SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS |
Registration Statements
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K |
Current Reports
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A |
Other
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
Securities offered to employees pursuant to employee benefit plans |
S-8 |
Registration Statements
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
A statement of beneficial ownership of common stock by certain persons |
SC 13G |
Other
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
A statement of beneficial ownership of common stock by certain persons |
SC 13G |
Other
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
Filing by person(s) reporting owned shares of common stock in a public company >5% |
SC 13D |
Other
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
CT ORDER |
CT ORDER |
Other
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 |
424B4 |
Registration Statements
|
AUTOLUS THERAPEUTICS PLC | View HTML | |
Registration of up to an additional 20% of securities for an offering filed on an F-1 |
F-1MEF |
Registration Statements
|
AUTOLUS THERAPEUTICS PLC | View HTML |
Data provided by Kaleidoscope.